| PFS | OS | ||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |||
Univariate analysis | ||||||||
Gender | Â | Â | Â | Â | Â | Â | Â | Â |
Male vs. Female | 1.242 | 0.746 | 2.070 | 0.404 | 0.907 | 0.540 | 1.523 | 0.711 |
Age | Â | Â | Â | Â | Â | Â | Â | Â |
<60 vs. ≥60 | 0.959 | 0.572 | 1.608 | 0.875 | 0.977 | 0.593 | 1.612 | 0.929 |
Tumor size | Â | Â | Â | Â | Â | Â | Â | Â |
<5 vs. ≥5 | 1.173 | 0.708 | 1.944 | 0.535 | 0.766 | 0.465 | 1.259 | 0.293 |
Location | Â | Â | Â | Â | Â | Â | Â | Â |
Colon vs. Rectum | 0.945 | 0.564 | 1.584 | 0.831 | 1.331 | 0.809 | 2.190 | 0.261 |
Differentiation | Â | Â | Â | Â | Â | Â | Â | Â |
Well vs. Middle vs. Poor | 0.746 | 0.521 | 1.068 | 0.109 | 1.000 | 0.696 | 1.437 | 0.999 |
T | Â | Â | Â | Â | Â | Â | Â | Â |
T1+T2 vs. T3 vs. T4a vs. T4b | 1.164 | .871 | 1.555 | 0.304 | 1.081 | .810 | 1.442 | 0.597 |
N | Â | Â | Â | Â | Â | Â | Â | Â |
N0 vs. N1 vs. N2a vs. N2b | 1.255 | 1.009 | 1.562 | 0.042* | 1.507 | 1.210 | 1.875 | <0.001*** |
TNM | Â | Â | Â | Â | Â | Â | Â | Â |
II+III vs. IVa vs. IVb | 2.027 | 1.383 | 2.971 | <0.001*** | 1.552 | 1.091 | 2.207 | 0.015* |
CEA (ng/ml) | Â | Â | Â | Â | Â | Â | Â | Â |
≤10 vs. >10 | 1.828 | 1.070 | 3.121 | 0.027* | 1.452 | 0.884 | 2.385 | 0.141 |
CA199 (U/ml) | ||||||||
≤37 vs. >37 | 1.620 | 0.973 | 2.698 | 0.064 | 1.123 | 0.684 | 1.842 | 0.647 |
CTCs | Â | Â | Â | Â | Â | Â | Â | Â |
Negative vs. Positive | 2.870 | 1.716 | 4.801 | <0.0001*** | 1.664 | 1.003 | 2.761 | 0.048* |
Multivariate analysis | ||||||||
N | Â | Â | Â | Â | Â | Â | Â | Â |
N0 vs. N1 vs. N2a vs. N2b | 1.169 | 0.930 | 1.469 | 0.180 | 1.499 | 1.198 | 1.876 | <0.001*** |
TNM | Â | Â | Â | Â | Â | Â | Â | Â |
IIÂ +Â III vs. IVa vs. IVb | 1.687 | 1.115 | 2.553 | 0.013* | 1.580 | 1.086 | 2.298 | 0.017* |
CEA (ng/ml) | Â | Â | Â | Â | Â | Â | Â | Â |
≤10 vs. >10 | 1.258 | 0.712 | 2.224 | 0.429 |  |  |  |  |
CTCs | Â | Â | Â | Â | Â | Â | Â | Â |
Negative vs. Positive | 1.993 | 1.141 | 3.483 | 0.015* | 1.148 | 0.679 | 1.943 | 0.606 |